According to a Research Report Published by Spherical Insights & Consulting, The Global Generative Artificial Intelligence (AI) in Healthcare Market Size is Expected to Grow from USD 1.5 Billion in 2023 to USD 29.8 Billion by 2033, at a CAGR of 34.84% during the forecast period 2023-2033.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/5985

Generative artificial intelligence (AI) in healthcare is the current trend of applying state-of-the-art machine learning models, such as generative adversarial networks (GANs) and more recently, large language models, to generate new meaningful content or insights out of existing data. Such a generative technology could synthesize data, simulate biological processes, or produce personalized content, leading to improved decisions, diagnosis, therapy, and healthcare research in general. Artificial intelligence is providing access to more personalized and efficient healthcare solutions and improving patient outcomes. Healthcare providers are adopting Gen AI, and more research is being done by life sciences researchers for Gen AI to push the entire global generative AI in the healthcare market. Furthermore, the increasing need for precision medicine and therapy continues driving demand for personalized healthcare into global generative artificial intelligence (AI) in the health space. The developments of medical imaging technologies receive more attention in an attempt to enhance the precision and effectiveness of disease diagnosis. However, the regulations, privacy concerns, high implementation costs, limited interoperability, potential biases, ethical issues, and a shortage of qualified personnel restrict the market growth.

Browse key industry insights spread across 261 pages with 120 Market data tables and figures & charts from the report on the Global Generative artificial intelligence (AI) in healthcare Market Size, Share, and COVID-19 Impact Analysis, By Component (Solutions and Services), By Application (Personalized Treatment, Patient Assistance, Patient Monitoring & Predictive Analytics, Medical Image Analysis & Diagnostics, Drug Discovery & Development, and Others), By End-Use (Healthcare Providers, Pharmaceutical and Life Science Companies, and Healthcare Payers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Buy Now Full Report: https://www.sphericalinsights.com/checkout/5985

The solution segment is anticipated to hold the greatest share of the global generative artificial intelligence (AI) in the healthcare market during the forecast period.

On the basis of the component, the global generative artificial intelligence (AI) in the healthcare market is divided into solutions and services. Among these, the solution segment is anticipated to hold the greatest share of the global generative artificial intelligence (AI) in the healthcare market during the forecast period. This is attributed to the AI in healthcare results in diagnostics, accelerated drug development, and precise patient care contribute to the market growth.

The medical image analysis & diagnostics segment is anticipated to hold the greatest share of the global generative artificial intelligence (AI) in healthcare market during the forecast period.

On the basis of the application, the global generative artificial intelligence (AI) in healthcare market is divided into personalized treatment, patient assistance, patient monitoring & predictive analytics, medical image analysis & diagnostics, drug discovery & development, and others. Among these, the medical image analysis & diagnostics segment is anticipated to hold the greatest share of the global generative artificial intelligence (AI) in healthcare market during the forecast period.  This is attributed to the medical image analysis & diagnostics, which is a set of processes for extracting clinically useful data and plays a pivotal role in advancing and shaping the healthcare industry, thus offering potential advancement in precision, which ultimately promotes market growth.

The healthcare providers segment is anticipated to grow at a rapid CAGR during the forecast period.

On the basis of the end-use, the global generative artificial intelligence (AI) in healthcare market is divided into healthcare providers, pharmaceutical and life science companies, and healthcare payers. Among these, the healthcare providers segment is anticipated to grow at a rapid CAGR during the forecast period. This is attributed to the healthcare providers which include clinics, hospitals, and diagnostic centers that use AI. AI has simplified medical procedures, improved diagnostics, and improved patient care, which has increased productivity, diagnostic accuracy, and overall healthcare delivery advancement. This has led to innovation and advancements in healthcare technology.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/5985

North America is expected to hold the greatest share of the global generative artificial intelligence (AI) in healthcare market over the projected timeframe.

North America is expected to hold the greatest share of the global generative artificial intelligence (AI) in healthcare market over the projected timeframe. The adoption and combination of advanced AI solutions are a result of both technological advancement and the region’s established healthcare infrastructure. The market is also driven by government and private sector R&D investments. The region’s top research institutions and AI-focused tech firms foster creative ecosystems. The effective focus on precision medicine and healthcare efficiency can be attributed to these factors.

Asia-Pacific is expected to grow at a rapid CAGR growth of the global generative artificial intelligence (AI) in healthcare market during the forecast period. Advanced AI technologies are being seamlessly adopted and integrated into the healthcare industry because of the Asia-Pacific region’s fast digital transformation and expanding tech ecosystem, which includes China, India, Japan, and Singapore. Furthermore, the development of generative AI has been accelerated by the presence of top-tier research institutions and robust industry-academia collaborations, which has revolutionized healthcare outcomes in the region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Global Generative Artificial Intelligence (AI) in Healthcare Market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global generative artificial intelligence (AI) in healthcare market are IBM Watson, Open AI, Google LLC, Microsoft Corporation, Johnson & Johnson, Neuralink Corporation, NioyaTech, Oracle, Saxon, Syntegra, Tencent Holdings Ltd., Epic Systems Corporation, Insilico Medicine, Nvidia Corporation, Abridge AI Inc., and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development

• In September 2024, Insilico Medicine revealed that it has partnered with Inimmune in a ground-breaking partnership. Insilico’s proprietary generative artificial intelligence (AI) technology, Chemistry42, will be used to speed up the development of next-generation immunotherapeutics. It increases Insilico’s standing as a pioneer in generative AI-powered medication development and broadens its market penetration in immunotherapy.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global generative artificial intelligence (AI) in healthcare market based on the below-mentioned segments:

By Component

• Solutions
• Services

By Application

• Personalized Treatment
• Patient Assistance
• Patient Monitoring & Predictive Analytics
• Medical Image Analysis & Diagnostics
• Drug Discovery & Development
• Others

By End-Use

• Healthcare Providers
• Pharmaceutical and Life Science Companies
• Healthcare Payers

Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

Browse Related Reports:

Global Impregnated Foam Dressing Market Size, Share, and COVID-19 Impact Analysis, By Application (Surgical, Diabetic, Pressure Ulcers, and Other), By End User (Hospitals, Home Care Settings, and Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

Global Fixed Human Anesthesia Workstation Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Standard Anesthesia Workstations, High-End Anesthesia Workstations, and Portable Anesthesia Workstations), By Application (General Surgery, Pediatric Surgery, Cardiac Surgery, Orthopedic Surgery, and Emergency Procedures), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

Global Cardioverter Defibrillator Device Market Size, Share, and COVID-19 Impact Analysis, By Type (Implantable Cardioverter Defibrillators, and External Cardioverter Defibrillators), By End User (Hospitals, Pre-Hospital, Public Access Market, Alternative Care, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

Global Medical Syringe Drive Systems Market Size, Share, and COVID-19 Impact By Product Type (Electronic Syringe Drive Systems and Mechanical Syringe Drive Systems), By Application (Hospitals, Ambulatory Surgical Centers, Clinics, Home Care Settings, and Others), By End-User (Healthcare Providers, Patients, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements.

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter